Uso de vidrio bioactivo en el tratamiento de osteomielitis aguda en un paciente pediátrico
Palabras clave:
osteomielitis aguda, BAG-S53P4, paciente pediátrico, biomaterial, tratamiento.Resumen
Introducción: La osteomielitis resulta una enfermedad grave en niños, por lo que requiere un diagnóstico y tratamiento precoz para minimizar las secuelas. El uso de vidrio bioactivo se considera una alternativa para rellenar defectos óseos después del curetaje y desbridamiento de la osteomielitis crónica. Sin embargo, hasta la fecha no hay datos de su uso en el tratamiento de la osteomielitis aguda en la población pediátrica.
Objetivo: Describir los resultados del uso de vidrio bioactivo en el tratamiento de osteomielitis aguda en un paciente pediátrico.
Presentación del caso: Paciente de ocho años con osteomielitis aguda de tibia por S. aureus resistente a meticilina. Recibió antibioticoterapia endovenosa y manejo quirúrgico para el control local; sin embargo, por pobre respuesta clínica hubo que aplicar vidrio bioactivo (BAG-S53P4 BonAlive® Granules, Finland). Evolucionó con excelentes resultados clínicos y paraclínicos, y una osteointegración completa del biomaterial en un seguimiento de tres años.
Conclusiones: El vidrio bioactivo BAG-S53P4 resultó un sustituto óseo eficaz, con excelentes resultados a largo plazo, sin efectos secundarios en el tratamiento de un paciente pediátrico con osteomielitis aguda; pero se requieren estudios adicionales.
Descargas
Citas
Howard AR, Isaacs D. Systematic review of duration and choice of systemic antibiotics therapy for acute haematogenous bacterial osteomyelitis in children. J Paed Child Health 2013;49(9):760-8. DOI: https://doi.org/10.1111/jpc.12251 2. Chiappini E, Mastrangelo G, Lazzeri S. A case of acute osteomyelitis: An update on diagnosis and treatment. Int J Environ Res Public Health. 2016;13(6):539. DOI: https://doi.org/10.3390/ijerph13060539
Yeo A, Ramachandran M. Acute haematogenous osteomyelitis in children. BMJ. 2014;348:g66. DOI: https://doi.org/10.1136/bmj.g66
Russell CD, Ramaesh R, Kalima P, Murray A, Gaston MS. Microbiological characteristics of acute osteoarticular infections in children. J Med Microbiol. 2015;64(4):446-53. DOI: https://doi.org/10.1099/jmm.0.000026
Thomsen I, Creech CB. Advances in the diagnosis and management of pediatric osteomyelitis. Curr Infect Dis Rep. 2011;13(5):451-60. DOI: https://doi.org/10.1007/s11908-011-0202-z
Drago L. A modern approach to biofilm-related orthopaedic implant infections. New York NY: Springer; 2017.
Ochsner PE, Borens O, Bodler PM, Brogger I, Eich G, Hefti F, et al. Infections of the musculoskeletal system-Basic principles, prevention, diagnosis and treatment. Grandvaux, Switzerland: Swiss orthopaedics and the Swiss Society for Infectious Diseases expert group “Infections of the musculoskeletal system”; 2016.
Ziegenhain F, Neuhaus V, Pape HC. Bioactive glass in the treatment of chronic osteomielitis-a valid option? OTA Int. 2021;4(3):105-6. DOI: https://doi.org/10.1097/OI9.0000000000000105
Ferrando A, Part J, Baeza J. Treatment of cavitary bone defects in chronic osteomyelitis: bioactive glass S53P4 vs. calcium sulphate antibiotic beads. J Bone Jt Infect. 2017;2(4):194-201. DOI: https://doi.org/10.7150/jbji.20404
Ronga M, Ferraro S, Fagetti A, Cherubino M, Valdatta L, Cherubino P. Masquelet technique for the treatment of a severe acute tibial bone loss. Injury. 2014;45(supl6):s111-5. DOI: https://doi.org/10.1016/j.injury.2014.10.033
Mühlhäusser J, Winkler J, Babst R, Beereers S. Infected tibia defect fractures treated with the Masquelet technique. Med. 2017;96(20):e6948. DOI: https://doi.org/10.1097/MD.0000000000006948
Ryan EJ, Ryan AJ, González A, Philippart A, Ciraldo F, Hobss C, et al. Collagen scaffolds functionalised with copper-eluting bioactive glass reduce infection and enhance osteogenesis and angiogenesis both in vitro and in vivo. Biomat. 2019;197:405-16. DOI: https://doi.org/10.1016/j.biomaterials.2019.01.031
Day RM. Bioactive glass stimulates the secretion of angiogenic growth factors and angiogenesis in vitro. Tissue Eng. 2005;11(5-6):768-77. DOI: https://doi.org/10.1089/ten.2005.11.768
Rahaman MN, Day DE, Bal BS, Fu Q, Jung S, Bonewald S, et al. Bioactive glass in tissue engineering. Acta Biomat. 2011;7(6):2355-73. DOI: https://doi.org/10.1016/j.actbio.2011.03.016
Peltola T, Jokinen M, Rahiala H, Levänen E, Rosenholm J, Kangasniemi J, et al. Calcium phosphate formation on porous sol-gel-derived SiO2 and CaO-P2O5-SiO2 substrates in vitro. J Biomed Mater Res. 1999;44(1):12-21. DOI: https://doi.org/10.1002/(SICI)1097-4636(199901)44:1%3C12::AID-JBM2%3E3.0.CO;2-E
Pereira MM, Clark AE, Hench LL. Calcium phosphate formation on solgel-derived bioactive glasses in vitro. J Biomed Mater Res. 1994;28(6):693-8. DOI: https://doi.org/10.1002/jbm.820280606
van Vugt TA, Geurts JAP, Arts JJC, Lindfors NC. Biomaterials in treatment of orthopedic infections. PJIs. 2017;41-68. DOI: https://doi.org/10.1016/B978-0-08-100205-6.00003-3
Lindfors N, Geurts J, Drago L, Arts JJ, Juutilainen V, Hyvönen P, et al. Antibacterial bioactive glass, S53P4, for chronic bone infections - a multinational study. Adv Exp Med Biol. 2017;971:81-92. DOI: https://doi.org/10.1007/5584_2016_156
Gonzalez M, Butini ME, Maiolo EM, Sessa L, Trampuz A. Antimicrobial activity of bioactive glass S53P4 against representative microorganisms causing osteomyelitis - Real-time assessment by isothermal microcalorimetry. Coll Surf B Bioint. 2020;189:110853. DOI: https://doi.org/10.1016/j.colsurfb.2020.110853
Bigoni M, Turati M, Zanchi N, Lombardo AS, Graci J, Omeljaniuk RJ, et al. Clinical applications of Bioactive glass S53P4 in bone infections: a systematic review. Eur Rev Med Pharmacol Sci. 2019;23(2supl):240-51. DOI: https://doi.org/10.26355/eurrev_201904_17498
Tanwar YS, Ferreira N. The role of bioactive glass in the management of chronic osteomyelitis: a systematic review of literature and current evidence. Infect Dis (Lond). 2020;52(4):219-26. DOI: https://doi.org/10.1080/23744235.2019.1695059
Cossio A, Graci J, Lombardo AS, Turati M, Melzi ML, Bigoni M, et al. Bilateral tibial Brodie’s abscess in a young patient treated with BAG-S53P4: case report. Ital J Pediatr. 2019;45(1):91. DOI: https://doi.org/10.1186/s13052-019-0685-z
